Across North America, the expanding life sciences sector and rising investments in advanced biomedical research are supporting the adoption of CSPG2 antibodies. The region's well-established pharmaceutical and biotechnology industries, sophisticated laboratory infrastructure, and increasing focus on proteomics, cell biology, and molecular characterization are creating favorable growth...